Autologous HTC Remains the Preferred Standard of Care for First-line Therapy of Mantle Cell Lymphoma_Timothy Fenske, MD; #IUCLS22-01
18:15
Lymphoma
Autologous HTC Remains the Preferred Standard of Care for First-line Therapy of Mantle Cell Lymphoma_Timothy Fenske, MD; #IUCLS22-01
Lymphoma Similar Videos
Similar Videos
-
Virtual Challenging Case Clinic: B-cell Lymphomas - CNS Lymphoma_Alvaro Alencar, MD
53:25
-
IUCLS 2023 Friday General Session_Sonali Smith, MD, FASCO_Andrew Evens, DO, MBA, MSc_Timothy Fenske, MD, MS
11:03
-
Virtual Challenging Case Clinic: B-cell Lymphomas - Chronic Lymphocytic Leukemia_Jennifer Brown, MD, PhD
49:09
